000 | 01331 a2200361 4500 | ||
---|---|---|---|
005 | 20250516130533.0 | ||
264 | 0 | _c20130617 | |
008 | 201306s 0 0 eng d | ||
022 | _a1399-6576 | ||
024 | 7 |
_a10.1111/aas.12010 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aFlaatten, H | |
245 | 0 | 0 |
_aThe Scandinavian Critical Care Trials Group: producing important new findings in challenging times. _h[electronic resource] |
260 |
_bActa anaesthesiologica Scandinavica _cFeb 2013 |
||
300 |
_a138-40 p. _bdigital |
||
500 | _aPublication Type: Editorial | ||
650 | 0 | 4 | _aClinical Trials as Topic |
650 | 0 | 4 |
_aCritical Care _xtrends |
650 | 0 | 4 |
_aDrug Industry _xlegislation & jurisprudence |
650 | 0 | 4 |
_aGlutamine _xtherapeutic use |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHydroxyethyl Starch Derivatives _xadverse effects |
650 | 0 | 4 |
_aIsotonic Solutions _xadverse effects |
650 | 0 | 4 |
_aPlasma Substitutes _xadverse effects |
650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
650 | 0 | 4 | _aResuscitation |
650 | 0 | 4 | _aRinger's Solution |
650 | 0 | 4 | _aScandinavian and Nordic Countries |
700 | 1 | _aHaney, M | |
700 | 1 | _aWernerman, J | |
773 | 0 |
_tActa anaesthesiologica Scandinavica _gvol. 57 _gno. 2 _gp. 138-40 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/aas.12010 _zAvailable from publisher's website |
999 |
_c22397474 _d22397474 |